Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Brachial Plexus

Aug 5, 2020/Clinical Summary

The brachial plexus is a vital network of nerves originating from the ventral rami of C5 through spinal nerve T1 transmitting signals for the entire upper extremity to supply both motor and sensory input.

Timed Up and Go Test (TUG)

Nov 15, 2024/Test & Measure

This test measures functional assessment of mobility, balance, and fall risk.

Proposed FY '22 SNF Rule: A PDPM Surprise; CMS Acknowledges Lower Therapy Rates

Apr 13, 2021/Review

CMS says the PDPM is 5% more costly than the previous payment system, and warns SNFs to not let finances "override" clinical judgment.

A Responsibility to Innovate: Managing the Trends Shaping the Future of Rehab

Nov 1, 2025/Feature

The APTA Future of Rehab Therapy Summit highlighted emerging technologies and partnerships changing rehabilitation and patient care.

Viewpoints: May 2023

May 1, 2023/Article

Kudos to two recent Defining Moment authors, and a PT with a rare condition works to remember her “why.”

Epic Lift Capacity Test (ELC)

Jun 16, 2022/Test & Measure

The EPIC Lift Capacity test (ELC) is used to evaluate lifting capacity through different vertical ranges necessary to carry out the occupational demands required for lifting on an occasional or frequent basis.

Targeting Fraud and Abuse in Home Health

Nov 1, 2016/Column

CMS launches a pre-claim review demonstration in 5 states. Here are the key points.

MACRA Makes Macro Changes

Sep 1, 2015/Column

As provisions of the new law take effect, PTs had best adopt quality measures and learn more about innovative care-delivery models being created in their communities.

APTA, ASHA, AOTA to Congress: Let's Take on the Fee Schedule — Here's How

Jun 28, 2023/News

Along with APTA Private Practice, the associations have a plan for reform that could dramatically alter the Medicare payment landscape.

Responding to Targeted Medical Review

Jul 1, 2017/Column

CMS is reviewing some therapy claims that exceed the $3,700 Medicare Part B threshold. Here's what to know, and what to do, if you are contacted